John Keohane - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

John Keohane

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

The American Journal of Gastroenterology|April 22, 2010

Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidityPaul Scully, Declan P McKernan, John Keohane, et al.

Inflammatory Bowel Diseases|October 14, 2009

Mycobacterium avium subsp. Paratuberculosis (MAP) as a modifying factor in Crohn's diseaseShomik Sibartie, Paul Scully, John Keohane, et al.

Scandinavian Journal of Gastroenterology|June 17, 2020

Irish data on the safety and efficacy of vedolizumab in the treatment of inflammatory bowel diseaseCiaran Judge, Neasa McGettigan, Timothy Ryan, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

The American Journal of Gastroenterology|April 22, 2010

Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidityPaul Scully, Declan P McKernan, John Keohane, et al.

Inflammatory Bowel Diseases|October 14, 2009

Mycobacterium avium subsp. Paratuberculosis (MAP) as a modifying factor in Crohn's diseaseShomik Sibartie, Paul Scully, John Keohane, et al.

Scandinavian Journal of Gastroenterology|June 17, 2020

Irish data on the safety and efficacy of vedolizumab in the treatment of inflammatory bowel diseaseCiaran Judge, Neasa McGettigan, Timothy Ryan, et al.

Pageof 2